From Epigenetic to Proteomic to Organ-Specific: Which Aging Biomarkers Are Closest to Clinical Use?
The biomarker field in longevity now has a familiar problem: it is producing more interesting measurements than medicine yet knows […]
The biomarker field in longevity now has a familiar problem: it is producing more interesting measurements than medicine yet knows […]
Few ideas in longevity science have spread faster than the promise of the aging clock. The sales pitch is simple